Quantifying early lung fibrosis using deep learning
Principal Investigator
Name
Joseph Jacob
Degrees
F.R.C.R., M.D.(Res).,
Institution
University College London
Position Title
Wellcome Trust Fellow
Email
About this CDAS Project
Study
NLST
(Learn more about this study)
Project ID
NLST-468
Initial CDAS Request Approval
Jan 15, 2019
Title
Quantifying early lung fibrosis using deep learning
Summary
Idiopathic pulmonary fibrosis (IPF), the most common fibrosining lung disease has a median patient survival of only 3-5 years. The prevalence of FLD is increasing in the Western world partly related to ageing within the general population and partly because of increased awareness of the disease. Unfortunately FLD is typically diagnosed at an advanced stage once patients are already physically impaired and patient decline is often rapid.
Diagnosis in turn is often delayed as CT appearances and lung function test profiles are only well characterized for established, relatively late-stage disease. Recognising FLD at an early stage is therefore essential to create a treatment window where disease that has not yet become extensive could potentially be controlled. We aim to use deep learning mechanisms to quantify lung damage and disease progression.
Diagnosis in turn is often delayed as CT appearances and lung function test profiles are only well characterized for established, relatively late-stage disease. Recognising FLD at an early stage is therefore essential to create a treatment window where disease that has not yet become extensive could potentially be controlled. We aim to use deep learning mechanisms to quantify lung damage and disease progression.
Aims
Quantify CT features suggestive of early lung fibrosis
Quantify CT features indicating rapidly progressive CT phenotypes of lung fibrosis
Collaborators
Prof Daniel Alexander
Prof Geoff Parker
Mr Moucheng Xu
Dr Cheung Wing Keung
Mr Ashkan Pakzad
Dr Arjun Nair